Publication

Endemic fungal infections in solid organ and hematopoietic cell transplant recipients enrolled in the Transplant-Associated Infection Surveillance Network (TRANSNET)

Downloadable Content

Persistent URL
Last modified
  • 03/05/2025
Type of Material
Authors
    C.A. Kauffman, University of MichiganA.G. Freifeld, University of NebraskaD.R. Andes, University of WisconsinJ.W. Baddley, University of Alabama BirminghamL. Herwaldt, University of IowaR.C. Walker, Mayo ClinicB.D. Alexander, Duke UniversityE.J. Anaissie, University of ArkansasK. Benedict, Centers for Disease Control and PreventionJ.I. Ito, City of Hope Comprehensive Cancer CenterK.M. Knapp, St. Jude Children’s Research HospitalGeorge Lyon III, Emory UniversityK.A. Marr, Fred Hutchinson Cancer Research CenterV.A. Morrison, University of MinnesotaB.J. Park, Centers for Disease Control and PreventionT.F. Patterson, University of TexasM.G. Schuster, University of PennsylvaniaTom Chiller, Emory UniversityP.G. Pappas, University of Alabama Birmingham
Language
  • English
Date
  • 2014-04-01
Publisher
  • Wiley: 12 months
Publication Version
Copyright Statement
  • © 2014 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
Final Published Version (URL)
Title of Journal or Parent Work
ISSN
  • 1398-2273
Volume
  • 16
Issue
  • 2
Start Page
  • 213
End Page
  • 224
Grant/Funding Information
  • This study was supported through CDC Grant 5U01CI000286-05 and grants from Merck & Co., Inc.; Astellas US, Inc.; Pfizer, Inc.; Schering-Plough Research Institute; and Enzon Pharmaceuticals, Inc.
Abstract
  • Background: Invasive fungal infections are a major cause of morbidity and mortality among solid organ transplant (SOT) and hematopoietic cell transplant (HCT) recipients, but few data have been reported on the epidemiology of endemic fungal infections in these populations. Methods: Fifteen institutions belonging to the Transplant-Associated Infection Surveillance Network prospectively enrolled SOT and HCT recipients with histoplasmosis, blastomycosis, or coccidioidomycosis occurring between March 2001 and March 2006. Results: A total of 70 patients (64 SOT recipients and 6 HCT recipients) had infection with an endemic mycosis, including 52 with histoplasmosis, 9 with blastomycosis, and 9 with coccidioidomycosis. The 12-month cumulative incidence rate among SOT recipients for histoplasmosis was 0.102%. Occurrence of infection was bimodal; 28 (40%) infections occurred in the first 6 months post transplantation, and 24 (34%) occurred between 2 and 11 years post transplantation. Three patients were documented to have acquired infection from the donor organ. Seven SOT recipients with histoplasmosis and 3 with coccidioidomycosis died (16%); no HCT recipient died. Conclusions: This 5-year multicenter prospective surveillance study found that endemic mycoses occur uncommonly in SOT and HCT recipients, and that the period at risk extends for years after transplantation.
Author Notes
  • Correspondence to: Carol A. Kauffman, MD, Infectious Diseases Section, VA Ann Arbor Healthcare System, 2215 Fuller Road, Ann Arbor, MI 48105, USA, Tel: 1 734 845 3460, Fax: 1 734 845 3290, ckauff@umich.edu
Keywords
Research Categories
  • Health Sciences, Immunology
  • Health Sciences, Epidemiology

Tools

Relations

In Collection:

Items